| 51 |
26930651 | Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies. | 2016 |
1 |
| 52 |
26963617 | Effects of Metformin on Tissue Oxidative and Dicarbonyl Stress in Transgenic Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein. | 2016 |
1 |
| 53 |
27619024 | The suppressive effects of metformin on inflammatory response of otitis media model in human middle ear epithelial cells. | 2016 Oct |
1 |
| 54 |
27893782 | Beneficial Effects of Metformin and/or Salicylate on Palmitate- or TNFα-Induced Neuroinflammatory Marker and Neuropeptide Gene Regulation in Immortalized NPY/AgRP Neurons. | 2016 |
2 |
| 55 |
27904436 | Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes. | 2016 |
1 |
| 56 |
27904616 | Effect of folic acid and metformin on insulin resistance and inflammatory factors of obese children and adolescents. | 2016 |
1 |
| 57 |
28002460 | Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice. | 2016 |
1 |
| 58 |
25560571 | Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus. | 2015 Feb |
1 |
| 59 |
25590211 | Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug. | 2015 Mar |
6 |
| 60 |
25817233 | AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells. | 2015 Jun 15 |
1 |
| 61 |
25889494 | A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells. | 2015 Apr 10 |
4 |
| 62 |
26120598 | Suppression of experimental arthritis through AMP-activated protein kinase activation and autophagy modulation. | 2015 Feb 28 |
1 |
| 63 |
26141671 | Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction. | 2015 Nov |
1 |
| 64 |
26320144 | Effects of metformin on mitochondrial function of leukocytes from polycystic ovary syndrome patients with insulin resistance. | 2015 Nov |
1 |
| 65 |
22841520 | The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose. | 2013 Jan |
1 |
| 66 |
23611575 | A successful case of pain management using metformin in a patient with adiposis dolorosa. | 2013 Jun |
1 |
| 67 |
23659985 | Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome. | 2013 Aug |
1 |
| 68 |
22570949 | The effects of metformin on inflammatory mediators in obese adolescents with insulin resistance: controlled randomized clinical trial. | 2012 |
1 |
| 69 |
22688336 | Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes. | 2012 Aug |
1 |
| 70 |
23091851 | [Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-gamma2 gene polymorphism]. | 2012 |
1 |
| 71 |
23677182 | [Effect of metformin on the expression of tumor necrosis factor-α, Toll like receptors 2/4 and C reactive protein in obese type-2 diabetic patients]. | 2012 Nov |
3 |
| 72 |
20034685 | Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus. | 2011 May 19 |
2 |
| 73 |
21338323 | Metformin counters both lipolytic/inflammatory agents-decreased hormone sensitive lipase phosphorylation at Ser-554 and -induced lipolysis in human adipocytes. | 2011 Oct |
1 |
| 74 |
21424914 | The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. | 2011 Dec |
1 |
| 75 |
21740847 | Beneficial effects of metformin on primary cardiomyocytes via activation of adenosine monophosphate-activated protein kinase. | 2011 Jun |
1 |
| 76 |
21954641 | [Efficacy of metformin as initial therapy in patients with coronary artery disease and diabetes type 2]. | 2011 Jan-Mar |
1 |
| 77 |
22673924 | Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver. | 2011 Nov |
1 |
| 78 |
20015525 | Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients. | 2010 Jun |
2 |
| 79 |
20371705 | Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. | 2010 Jul |
4 |
| 80 |
18597869 | Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. | 2009 May 15 |
6 |
| 81 |
19494326 | Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. | 2009 Jun 15 |
1 |
| 82 |
18082089 | [Rosuvastatin and metformin decrease inflammation and oxidative stress in patients with hypertension and dyslipidemia]. | 2007 Dec |
1 |
| 83 |
16636195 | Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. | 2006 Jun |
4 |
| 84 |
15690319 | Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin. | 2005 Feb |
1 |
| 85 |
11523631 | Mechanisms involved in tumor necrosis factor-alpha induction of insulin resistance and its reversal by thiazolidinedione(s). | 2001 Aug |
2 |
| 86 |
9505147 | Metformin increases circulating tumour necrosis factor-alpha levels in non-obese non-diabetic patients with coronary heart disease. | 1998 Jan |
2 |
| 87 |
9288574 | Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells. | 1997 Aug |
3 |